(Posted by Desinie Smith)
A number of improved treatments will be available soon, and Novatis' Fingolimod could lead the way
Bullock is in " the best shape I've been in for years" thanks to Fingolimod. When Thomas Bullock was diagnosed with multiple sclerosis in 2001, several new treatments for the incurable , nerve-destroying condition had just hit the market. The automotive worker from Ontario spent two years on Bayer's blockbuster Betaseron, an injectable drug that can suppress a hyperactive immune system. But instead of getting better,Bullock endured constant flu-like
symptoms and numbness in his limbs. When he developed severe nerve damage,he ditched the injections. " My body just couldn't handle it," recalls Bullock , now 41.
To read the rest of the article on businessweek.com click here.
Labels: PERSEVERANCE
